低密度脂蛋白受体
PCSK9
内体
内吞作用
溶酶体
细胞生物学
内化
前蛋白转化酶
可欣
生物化学
化学
受体
细胞内
生物
胆固醇
脂蛋白
酶
作者
Yangyang Guan,Xiaomin Liu,Zetian Yang,Xinyu Zhu,Min Liu,Mingkun Du,Xiaowei Pan,Yan Wang
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2025-03-12
卷期号:151 (21): 1512-1526
被引量:27
标识
DOI:10.1161/circulationaha.124.072336
摘要
PCSK9 promotes LDLR degradation by preventing SNX17-mediated LDLR recycling. Patients with sequence variations in FH leading to defects in LDLR recycling are resistant to PCSK9 inhibitors. Genetic diagnosis and alternative drugs independent of LDLR will be needed for treatment of these patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI